Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Acinetobacter spp are gram-negative, aerobic, coccobacillary bacteria, which are generally non–lactose-fermenting, nonfastidious, catalase positive, oxidase negative, and nonmotile, though their description of being “nonmotile” is questioned. The Gram stain appearance of Acinetobacter spp is highly dependent on the life cycle. In the early growth phases, Acinetobacter spp appear rod shaped. In the stationary phase, they acquire a coccobacillary morphology. A. baumannii and other members of the A. calcoaceticus-baumannii (Acb) complex are the most common human pathogens among the more than 70 validated Acinetobacter spp (see E-Table 283-1 for 30 representative species) and more than 20 species that are reported but unvalidated and unnamed.
Acinetobacter spp are present in food and water, and they can colonize many body surfaces and cause infection in almost any organ system. In the United States, Acinetobacter species are a leading cause of ventilator-associated pneumonia. The majority of infections originally was observed only in critically ill, immunocompromised, or injured hosts in intensive care units (ICUs), but infections can occur in non-ICU patients and patients in long-term care settings. Acinetobacter spp also can cause superinfections complicating the course of patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Since the coronavirus disease 2019 (COVID-19) pandemic, the U.S. Centers for Disease Control and Prevention (CDC) reported a 35% increase in hospital-based carbapenem-resistant Acinetobacter and a 78% increase in hospital-onset cases.
For example, in tropical regions of China, Asia, Australia, and the South Pacific, Acinetobacter spp can account for more than 15% of cases of community-acquired pneumonia. The common comorbid conditions predisposing to community-acquired pneumonia due to Acinetobacter spp are mainly chronic obstructive pulmonary disease ( Chapter 76 ), renal disease ( Chapter 116 ), diabetes mellitus ( Chapter 210 ), and alcohol use disorder. In Saudi Arabia, Acinetobacter is one of the most common pathogens associated with late-onset and recurrent ventilator-associated pneumonia.
Outbreaks of A. baumannii skin infections were common among U.S. military personnel in Iraq and Afghanistan. Acinetobacter infection also has become increasingly common among patients in burn units ( Chapter 97 ), sometimes resulting in unit-wide outbreaks. The frequency of Acinetobacter infections is often greater in the summer than in other seasons.
SPECIES | FORMER NAMES & SYNONYMS | TYPE STRAIN | REFERENCES |
---|---|---|---|
Acinetobacter albensis | Novel | CCM 8611 | doi: 10.1099/ijsem.0.000511 |
Acinetobacter apis | Novel | JCM 18575 | doi: 10.1007/s12275-014-4078-0 |
Acinetobacter baumannii | Acinetobacter genomospecies 2 | ATCC 19606 | doi: 10.1099/ijsem.0.000932; doi: 10.1099/00207713-36-2-228 |
Acinetobacter baylyi | Novel | DSM 14961 | doi: 10.1099/ijs.0.02486-0 |
Acinetobacter beijerinckii | Novel | DSM 22901 | doi: 10.1099/ijs.0.001230-0 |
Acinetobacter bereziniae | Acinetobacter genomospecies 10 | ATCC 17924 | doi: 10.1099/ijsem.0.000932; doi: 10.1099/ijs.0.013656-0 |
Acinetobacter bohemicus | Novel; synonym: Acinetobacter pakistanensis | DSM 102855 | doi: 10.1016/j.syapm.2014.07.001; doi: 10.1099/ijsem.0.001530 |
Acinetobacter bouvetii | Novel | DSM 14964 | doi: 10.1099/ijs.0.02486-0 |
Acinetobacter calcoaceticus | Acinetobacter genomospecies 1 | ATCC 23055 | doi: 10.1128/jb.95.5.1520-1541.1968; doi: 10.1099/ijsem.0.000932; doi: 10.1099/00207713-36-2-228 |
Acinetobacter colistiniresistens | Acinetobacter genomospecies 13BJ or 14TU | DSM 107593 | doi: 10.1099/ijsem.0.000932; doi: 10.1016/0923-2508(89)90021-1; doi: 10.1099/ijsem.0.001903 |
Acinetobacter courvalinii | Acinetobacter genomospecies 14BJ | CIP 110480 | doi: 10.1016/0923-2508(89)90021-1; doi: 10.1099/ijsem.0.000932 |
Acinetobacter disperses | Acinetobacter genomospecies 17 | CIP 110500 | doi: 10.1099/ijsem.0.000932 |
Acinetobacter genomospecies 15BJ | Novel | N/A | doi: 10.1016/0923-2508(89)90021-1 |
Acinetobacter genomospecies 16BJ | Novel | N/A | doi: 10.1016/0923-2508(89)90021-1 |
Acinetobacter genomospecies 6 | Novel | N/A | doi: 10.1111/j.1699-0463.1989.tb00449.x |
Acinetobacter gerneri | Novel | DSM 14967 | doi: 10.1099/ijs.0.02486-0 |
Acinetobacter guillouiae | Acinetobacter genomospecies 11 | ATCC 11171 | doi: 10.1099/ijsem.0.000932; doi: 10.1099/ijs.0.013656-0 |
Acinetobacter haemolyticus | Acinetobacter genomospecies 4 | ATCC 17906 | doi: 10.1099/ijsem.0.000932; doi: 10.1099/00207713-36-2-228 |
Acinetobacter johnsonii | Acinetobacter genomospecies 7 | ATCC 17909 | doi: 10.1099/ijsem.0.000932; doi: 10.1099/00207713-36-2-228 |
Acinetobacter junii | Acinetobacter genomospecies 5; synonym: Acinetobacter grimontii | ATCC 17908 | doi: 10.1099/ijsem.0.000932; doi: 10.1099/00207713-36-2-228; doi: 10.1099/ijs.0.65129-0 |
Acinetobacter lwoffii | Acinetobacter genomospecies 9 | ATCC 15309 | doi: 10.1099/ijsem.0.000932; doi: 10.1128/jb.95.5.1520-1541.1968; doi: 10.1099/00207713-36-2-228; doi: 10.1016/j.syapm.2018.10.004 |
Acinetobacter nosocomialis | Acinetobacter genomospecies 13TU | DSM 102856 | doi: 10.1099/ijsem.0.000932; doi: 10.1016/j.resmic.2011.02.006 |
Acinetobacter parvus | Novel | DSM 16617 | doi: 10.1099/ijs.0.02631-0 |
Acinetobacter pittii | Acinetobacter genomospecies 3 | ATCC 19004 | doi: 10.1099/ijsem.0.000932; doi: 10.1016/j.resmic.2011.02.006 |
Acinetobacter radioresistens | Acinetobacter genomospecies 12 | ATCC 43998 | doi: 10.1099/ijsem.0.000932; doi: 10.1111/j.1699-0463.1989.tb00449.x. |
Acinetobacter schindleri | Novel | ATCC BAA-618 | doi: 10.1099/00207713-51-5-1891 |
Acinetobacter seifertii | “close to 13TU” | DSM 102854 | doi: 10.1099/ijs.0.000043 |
Acinetobacter tandoii | Novel | DSM 14970 | doi: 10.1099/ijs.0.02486-0 |
Acinetobacter tjernbergiae | Novel | DSM 14971 | doi: 10.1099/ijs.0.02486-0 |
Acinetobacter townerii | Novel | DSM 14962 | doi: 10.1099/ijs.0.02486-0 |
Acinetobacter ursingii | Novel | ATCC BAA-617 | doi: 10.1099/00207713-51-5-1891 |
Acinetobacter variabilis | Acinetobacter genomospecies 15TU | DSM 102977 | doi: 10.1099/ijsem.0.000932; doi: 10.1099/ijs.0.000028 |
Acinetobacter venetianus | Novel | ATCC 31012 | doi: 10.1016/S0923-2508(97)85244-8; doi: 10.1099/ijs.0.003541-0 |
∗ Genome species designations are added. Type strain accession numbers are provided for species validly published under the International Code of Nomenclature of Prokaryotes (ICNP), American Type Culture Collection (ATCC), Collection de l’Institut Pasteur (CIP), German Collection of Microorganisms and Cell Cultures (DSM), or Japan Collection of Microorganisms (JCM).
Acinetobacter spp colonize the oropharynx and tracheostomy tubes in patients on ventilators, so it is not surprising that the upper respiratory tract is the most common site for infection. The main factors associated with health care–associated pneumonia due to Acinetobacter spp are mechanical ventilation, previous antibiotic exposure, ICU stay, surgery, and underlying pulmonary disease. In hospital environments, Acinetobacter spp can withstand drying (desiccation) and may even be transmitted by aerosol/respiratory droplet. Among the resistance genes found in Acinetobacter spp are a large collection of genes encoding β-lactamases, aminoglycoside-modifying enzymes, and many efflux pumps.
The most common infections are respiratory (pneumonia), blood stream (bacteremia), urinary tract, wound, skin and soft tissue, and burn infections; osteomyelitis secondary to trauma, and meningitis. Acinetobacter spp infections have few distinguishing features except, in some instances, skin manifestations.
The two distinct syndromes associated with respiratory tract infection due to Acinetobacter are community-acquired pneumonia and health care–associated pneumonia ( Chapter 85 ). Community-acquired pneumonia due to Acinetobacter species is associated with a high incidence of bacteremia, acute respiratory distress syndrome ( Chapter 90 ), sepsis, and death, with mortality rates sometimes exceeding 50%. Rarely, community-acquired pneumonia due to Acinetobacter species can be manifested with consolidation and multiple lung abscesses.
More frequently, Acinetobacter spp are a cause of pneumonia in patients who have risk factors for antimicrobial resistant organisms, often manifested as ventilator-associated pneumonia ( Chapter 85 ). Health care–associated pneumonia due to Acinetobacte r largely resembles the clinical spectrum of gram-negative pneumonias (bilateral infiltrates, pleural effusion, cavitations, hypoxemia, and bacteremia). Most cases are in patients on ventilators.
Blood stream infection due to Acinetobacter spp is often a consequence of infection of intravenous catheters (i.e., central line–associated blood stream infection) or is secondary to health care–associated pneumonia. Less commonly, wound infections can cause bacteremia. Infective endocarditis ( Chapter 61 ) is uncommon, with about 40% of cases involving a prosthetic valve.
Urinary tract infections are only rarely caused by Acinetobacter spp. An indwelling bladder catheter is the major risk factor.
Traumatic or postoperative wounds, burns ( Chapter 97 ), and skin and soft tissue infections are among the most common sites of Acinetobacter infections. Prior antibiotic use or devitalized tissues are predisposing factors. The spectrum of infection can range from cellulitis to necrotizing fasciitis.
Necrotizing skin and soft tissue infections with A. baumannii occur in hosts with underlying comorbidities (e.g., trauma, cirrhosis), especially associated with the use of central venous catheters and parenteral nutrition, Acinetobacter spp–associated skin infections can be manifested with a peau d’orange appearance, with overlying tiny vesicles ( Fig. 283-1 ), and, when untreated, can progress to necrotizing infection with bullae (hemorrhagic and nonhemorrhagic). Concomitant bacteremia is common.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here